Taylor O'Brien

Taylor O'Brien, a recovering startup founder, has transitioned to becoming an Investor/Trader focusing on OTC Pink Sheet Reverse Mergers and heavily invested in BioTech/AI innovations.

Passionate about eradicating infectious diseases and improving healthcare, particularly targeting diseases like HIV and COVID, while working towards preventing future pandemics.

Primary holding since Sept 2020 is Enzolytics ($enzc), a company with monoclonal antibodies utilizing AI technology to target virus escape prevention and cure development.

Continues to advocate for evolving industries through technology convergence, innovative business models, and IT consumerization at aota.io.

A background in Instructional Design & Technology, Communication Design, and Psychology from California State University-Chico, along with high school education from Bellarmine College Preparatory.

Professional experience includes roles as Founder & CEO at aota.io, Senior Product Manager & Director of Business Development at Kanler, and various project management positions at Walters & Wolf.

Formerly contributed to instructional design projects at CSU Chico, interned with Walters & Wolf, and worked at Cinnabar Hills Golf Club.

Despite past startup challenges, Taylor remains dedicated to innovation, health, and potential retirement while staying open to future entrepreneurial ventures.